Search research articles
Contact Us
Filters
Showing results (1-10 of 23) with videos related to
Page
of 3
Sort By:
International Journal of Surgery Case Reports
|
May 15, 2023
Primary thyroid rhabdomyosarcoma in an adult: A challenging case with histomolecular diagnosis and literature review
Ziyad Alsugair, Fabien Calcagno, Jean-Christophe Lifante, et al.
Cancer Chemotherapy and Pharmacology
|
April 29, 2017
Hemodialysis does not impact axitinib exposure: clinical case of a patient with metastatic renal cell carcinoma
Antoine Thiery-Vuillemin, Emeline Orillard, Guillaume Mouillet, et al.
Clinical Genitourinary Cancer
|
December 4, 2018
Economic Burden of Metastatic Clear-Cell Renal Cell Carcinoma for French Patients Treated With Targeted Therapies
Tiphaine Cholley, Antoine Thiery-Vuillemin, Samuel Limat, et al.
Clinical Medicine Insights. Oncology
|
July 12, 2016
Efficacy, Safety and Cost of Regorafenib in Patients with Metastatic Colorectal Cancer in French Clinical Practice
Fabien Calcagno, Sabrina Lenoble, Zaher Lakkis, et al.
Clinical Medicine Insights. Oncology
|
January 31, 2013
Safety and efficacy of cabazitaxel in the docetaxel-treated patients with hormone-refractory prostate cancer
Fabien Calcagno, Thierry Nguyen, Erion Dobi, et al.
Expert Opinion on Drug Safety
|
February 24, 2010
Safety profile of new anticancer drugs
Laura Mansi, Antoine Thiery-Vuillemin, Thierry Nguyen, et al.
Seminars in Oncology
|
June 12, 2020
Targeted and immune therapies among patients with metastatic renal carcinoma undergoing hemodialysis: A systemic review
Elodie Klajer, Louis Garnier, Morgan Goujon, et al.
International Journal of Cancer
|
November 22, 2019
Metronomic cyclophosphamide induces regulatory T cells depletion and PSA-specific T cells reactivation in patients with biochemical recurrent prostate cancer
Caroline Laheurte, Antoine Thiery-Vuillemin, Fabien Calcagno, et al.
Clinical Genitourinary Cancer
|
October 26, 2017
Factors Influencing Overall Survival for Patients With Metastatic Clear-Cell Renal-Cell Carcinoma in Daily Practice
Antoine Thiery-Vuillemin, Tiphaine Cholley, Fabien Calcagno, et al.
Bulletin Du Cancer
|
July 5, 2020
Activity and tolerability of maintenance avelumab immunotherapy after first line polychemotherapy including platinum in patients with locally advanced or metastatic squamous cell penile carcinoma: PULSE
Noémie Gassian, Alexandre Frontczak, Guillaume Mouillet, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 23) with videos related to
Sort By:
Page
of 3
International Journal of Surgery Case Reports
|
May 15, 2023
Primary thyroid rhabdomyosarcoma in an adult: A challenging case with histomolecular diagnosis and literature review
Ziyad Alsugair, Fabien Calcagno, Jean-Christophe Lifante, et al.
Cancer Chemotherapy and Pharmacology
|
April 29, 2017
Hemodialysis does not impact axitinib exposure: clinical case of a patient with metastatic renal cell carcinoma
Antoine Thiery-Vuillemin, Emeline Orillard, Guillaume Mouillet, et al.
Clinical Genitourinary Cancer
|
December 4, 2018
Economic Burden of Metastatic Clear-Cell Renal Cell Carcinoma for French Patients Treated With Targeted Therapies
Tiphaine Cholley, Antoine Thiery-Vuillemin, Samuel Limat, et al.
Clinical Medicine Insights. Oncology
|
July 12, 2016
Efficacy, Safety and Cost of Regorafenib in Patients with Metastatic Colorectal Cancer in French Clinical Practice
Fabien Calcagno, Sabrina Lenoble, Zaher Lakkis, et al.
Clinical Medicine Insights. Oncology
|
January 31, 2013
Safety and efficacy of cabazitaxel in the docetaxel-treated patients with hormone-refractory prostate cancer
Fabien Calcagno, Thierry Nguyen, Erion Dobi, et al.
Expert Opinion on Drug Safety
|
February 24, 2010
Safety profile of new anticancer drugs
Laura Mansi, Antoine Thiery-Vuillemin, Thierry Nguyen, et al.
Seminars in Oncology
|
June 12, 2020
Targeted and immune therapies among patients with metastatic renal carcinoma undergoing hemodialysis: A systemic review
Elodie Klajer, Louis Garnier, Morgan Goujon, et al.
International Journal of Cancer
|
November 22, 2019
Metronomic cyclophosphamide induces regulatory T cells depletion and PSA-specific T cells reactivation in patients with biochemical recurrent prostate cancer
Caroline Laheurte, Antoine Thiery-Vuillemin, Fabien Calcagno, et al.
Clinical Genitourinary Cancer
|
October 26, 2017
Factors Influencing Overall Survival for Patients With Metastatic Clear-Cell Renal-Cell Carcinoma in Daily Practice
Antoine Thiery-Vuillemin, Tiphaine Cholley, Fabien Calcagno, et al.
Bulletin Du Cancer
|
July 5, 2020
Activity and tolerability of maintenance avelumab immunotherapy after first line polychemotherapy including platinum in patients with locally advanced or metastatic squamous cell penile carcinoma: PULSE
Noémie Gassian, Alexandre Frontczak, Guillaume Mouillet, et al.
Page
of 3